Free cash flow swung from $6.0B in 2025Q4 to -$7.0B in 2026Q1, with working capital outflows of $7.1B in 2026Q1 and capital expenditures peaking at 13.2% of revenue, while dividends and buybacks totaled $5.4B and $10.3B respectively.
Jbs N.V. (JBS) cash flow statement — 12-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 |
|---|
| Cash from Operations | 13.09B | 15.49B | 23.56B | 11.5B | 13.33B | 21.48B | 23.78B | 13.77B | 7.44B | 5.2B | 3.67B | 7.38B | 8.99B |
| Operating CF Margin % | - | 3.29% | 5.65% | 3.16% | 3.47% | 5.93% | 8.8% | 6.73% | 4.1% | 3.19% | 2.15% | 4.53% | 7.46% |
| Operating CF Growth % | -107.96% | -34.23% | 104.87% | -13.76% | -37.93% | -9.68% | 72.73% | 85% | 43.02% | 41.9% | -50.34% | -17.83% | - |
| Net Income | 6.41B | 11.1B | 9.62B | -1.06B | 15.46B | 20.49B | 4.6B | 6.07B | 25.2M | 534.2M | 233.56M | 4.64B | 2.04B |
| Depreciation & Amortization | 11.79B | 12.63B | 11.81B | 10.73B | 9.85B | 9.03B | 7.84B | 6.31B | 4.8B | 4.47B | 4.5B | 3.69B | 2.55B |
| Stock-Based Compensation | 46.49M | 0 | 85.6M | 34.42M | 39.13M | 63.43M | -5.25M | 49.19M | 118.11M | 122.64M | 143.3M | 39.74M | 13.01M |
| Deferred Taxes | 1.24B | -361.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -494.09M | 3.99B | 9.39B | -1.61B | -3.16B | 12.74B | 13.37B | 4.71B | 4.52B | 1.95B | 599.92M | -190.33M | 4.94B |
| Working Capital Changes | -5.94B | -11.86B | -7.34B | 3.41B | -8.85B | -20.84B | -2.02B | -3.37B | -2.02B | -1.87B | -1.81B | -797.57M | -548.12M |
| Change in Receivables | -981.52M | -1.45B | -2.02B | 3.13B | -1.3B | -4.27B | 778.49M | -259.22M | 673.18M | -234.03M | -225.97M | 1.05B | 241.82M |
| Change in Inventory | -2.94B | -4.58B | -4.73B | -300.66M | -6.78B | -11.79B | -3.53B | -3.13B | -2.13B | -1.06B | -1.16B | -866.69M | -1.61B |
| Change in Payables | 2.87B | 3.01B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -11.15B | -12.56B | -7.73B | -7.02B | -13.12B | -18.86B | -7.83B | -5.85B | -1.74B | -2.43B | -3.54B | -20.76B | -4.28B |
| Capital Expenditures | -10.98B | -11.4B | -8.08B | -7.49B | -11.23B | -9.62B | -5.99B | -4.24B | -2.83B | -3.11B | -3.48B | -5.45B | -3.57B |
| CapEx % of Revenue | 2.87% | 2.42% | 1.94% | 2.06% | 2.92% | 2.65% | 2.22% | 2.07% | 1.56% | 1.91% | 2.04% | 3.35% | 2.96% |
| Acquisitions | 156.59M | 394.77M | -31.46M | -17.16M | -1.98B | -9.34B | -2.19B | -2.24B | -45.07M | -1.85B | -482.54M | -15.47B | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -211.44M | -285.38M | 382.02M | 485.19M | 81.04M | 102.65M | 339.15M | 625.42M | 1.13B | 2.53B | 423.38M | 169.72M | -707.41M |
| Cash from Financing | 2.9B | -9.97B | -7.3B | 5.01B | -8.76B | -844.5M | -9.02B | -6.44B | -9.99B | -634.37M | -8.1B | 15.17B | 876.88M |
| Debt Issued (Net) | 9.19B | 7.15B | -1.65B | 7.45B | 264.71M | 17.73B | -5.6B | -6.4B | -9.5B | -328.63M | 745.56M | 9B | 1.15B |
| Equity Issued (Net) | -11.63B | -3.19B | -44.49M | 0 | -3.65B | -10.6B | -1.27B | 0 | -498.19M | -255.94M | -821.14M | -1.78B | -64.23M |
| Dividends Paid | -781.51M | -8.81B | -4.44B | -2.22B | -4.44B | -7.4B | -1.44B | -5.98M | -126.88M | -93.35M | -1.1B | -482.73M | -219.88M |
| Share Repurchases | -11.63B | -3.19B | -44.49M | 0 | -3.65B | -10.6B | -1.27B | 0 | -498.19M | -255.94M | -821.14M | -1.78B | -64.23M |
| Other Financing | 6.12B | -5.12B | -1.16B | -218.37M | -939.51M | -575.4M | -712.53M | -38.77M | 135.29M | 43.55M | -6.92B | 8.42B | 7.03M |
| Net Change in Cash | 4.76B | -5.71B | 12.64B | 8.94B | -10.06B | 3.56B | 9.65B | 1.1B | -2.81B | 2.39B | -9.49B | 3.93B | 14.91B |
| Free Cash Flow | 2.14B | 4.13B | 15.47B | 4.01B | 2.11B | 11.86B | 17.8B | 9.53B | 4.62B | 2.09B | 187.16M | 1.93B | 5.42B |
| FCF Margin % | 0.56% | 0.88% | 3.71% | 1.1% | 0.55% | 3.27% | 6.59% | 4.66% | 2.54% | 1.28% | 0.11% | 1.19% | 4.5% |
| FCF Growth % | -71.62% | -73.32% | 286.2% | 90.15% | -82.23% | -33.37% | 86.75% | 106.46% | 120.61% | 1017.79% | -90.31% | -64.35% | - |
| FCF per Share | 2.09 | 3.86 | 6.98 | 1.81 | 0.93 | 4.78 | 6.70 | 3.57 | 1.73 | 0.74 | 0.07 | 0.67 | 1.88 |
| FCF Conversion (FCF/Net Income) | 0.33x | 1.40x | 2.45x | -10.84x | 0.84x | 1.01x | 5.17x | 2.27x | 295.35x | 9.74x | 15.70x | 1.59x | 4.41x |
| Interest Paid | 443.97M | 0 | 8.02B | 6.44B | 4.8B | 3.94B | 3.5B | 3.6B | 4.4B | 3.91B | 4.12B | 4.14B | 0 |
| Taxes Paid | 181.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying JBS stock.
Jbs N.V. (JBS) generated $15.49B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Jbs N.V. (JBS) generated $4.13B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Jbs N.V. (JBS) spent $11.40B on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Jbs N.V. (JBS) returned $8.81B to shareholders via cash dividends and spent $3.19B on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
High leverage and margin compression
Metrics are mathematically derived from official filings.
Earnings Quality Diverges Sharply
In 2026Q2, operating cash flow of $4.2B contrasted with a net loss of $102.1M, yielding an OCF/NI of -41.5, per the cash flow statement, indicating significant non-cash adjustments.
The negative net income alongside positive operating cash flow suggests that depreciation and amortization ($3.3B) and working capital changes are masking underlying operational losses. This divergence may indicate that reported earnings are not a reliable indicator of cash generation, and investors should monitor whether this pattern persists.
Free Cash Flow Volatility Intensifies
Free cash flow swung from $6.0B in 2025Q4 to -$7.0B in 2026Q1, with FCF margin dropping from 4.7% to -6.3%, based on reported quarterly data, highlighting extreme quarter-to-quarter instability.
The erratic FCF pattern, including a negative print in 2026Q1, suggests that the company's cash generation is highly sensitive to working capital swings and capex timing. This volatility may complicate debt servicing and capital allocation, especially given the elevated leverage ratio of 2.40.
Capital Intensity Pressures Cash Flow
Capital expenditures averaged $2.6B per quarter over the last ten quarters, with CapEx/Revenue peaking at 13.2% in 2026Q2, as per the cash flow data, indicating rising investment needs amid revenue contraction.
The elevated capex relative to revenue, particularly in the latest quarter, suggests that JBS is maintaining or expanding its asset base despite declining sales. This may reflect maintenance requirements or strategic investments, but it consumes cash that could otherwise be used for debt reduction, given the strained balance sheet.
Working Capital Swings Dominate Cash Flow
Working capital changes were negative in seven of the last ten quarters, with a $7.1B outflow in 2026Q1, according to the cash flow statement, indicating significant cash absorption from operations.
The persistent negative working capital changes, especially the large outflow in 2026Q1, suggest that JBS is experiencing inventory build-ups or delayed collections, possibly due to market disruptions. This pattern may indicate inefficiencies in managing receivables and inventory, which could strain liquidity if not reversed.
Dividends and Buybacks Strain Cash
Dividends paid totaled $5.4B in 2026Q2, while buybacks reached $10.3B in 2025Q3, based on the cash flow data, indicating aggressive shareholder returns despite negative free cash flow in some quarters.
The substantial cash outflows for dividends and buybacks, particularly in quarters with negative FCF, suggest that JBS is prioritizing shareholder returns over balance sheet repair. This may increase financial risk given the high debt levels and could limit flexibility if earnings remain under pressure.
Cumulative Earnings vs Cash Gap Widens
Over the last ten quarters, cumulative net income totaled $21.2B while operating cash flow reached $39.8B, per the cash flow data, indicating a positive cumulative gap of $18.6B.
The cumulative excess of operating cash flow over net income suggests that earnings are being conservatively stated, possibly due to large non-cash charges like depreciation. However, the recent quarters show a reversal, with net income turning negative, which may signal that the historical cash flow advantage is eroding.
What Could Invalidate the Base Case
The 2026Q2 revenue collapse and negative EPS suggest that the company may be facing a structural break, not just cyclical headwinds, which could challenge the narrative of a diversified global protein platform.
The cash flow statement may obscure the severity of operational deterioration through large non-cash adjustments and working capital timing. Investors should scrutinize whether the positive operating cash flow in 2026Q2 is sustainable or merely a result of aggressive working capital management, as the underlying earnings power appears strained.